title: Candesartan cilexetil in children and adolescents aged 1 to <17 years with hypertension: profile report.
authors.affiliation: Adis, a Wolters Kluwer Business, Auckland, New Zealand. demail@adis.co.nz
authors.forename: Sheridan M
authors.initials: SM
authors.lastname: Hoy
authors.forename: Gillian M
authors.initials: GM
authors.lastname: Keating
mesh_terms: D000293:Adolescent; D000959:Antihypertensive Agents / Q000097:blood / Q000627:therapeutic use*; D001562:Benzimidazoles / Q000097:blood / Q000627:therapeutic use*; D001713:Biphenyl Compounds / Q000097:blood / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D004305:Dose-Response Relationship, Drug; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D006973:Hypertension / Q000097:blood / Q000188:drug therapy* / Q000453:epidemiology*; D007223:Infant; D008297:Male; D011355:Prodrugs / Q000378:metabolism / Q000627:therapeutic use*; D058028:Research Report; D013777:Tetrazoles / Q000097:blood / Q000627:therapeutic use*
chemical_list: D000959:Antihypertensive Agents; D001562:Benzimidazoles; D001713:Biphenyl Compounds; D011355:Prodrugs; D013777:Tetrazoles; C077793:candesartan cilexetil